Monash IVF Group

Monash IVF Group has over five decades of experience in assisted reproductive technology. The company pioneered the world’s first successful IVF pregnancy in the early days of the field. It offers a comprehensive suite of fertility treatments—including advanced embryo culture techniques like blastocyst transfer—alongside genetic testing such as preimplantation genetic diagnosis/screening and non-invasive prenatal blood tests. The group also provides diagnostic obstetric/gynaecological ultrasound services. Their innovations include developing Menevit to support male fertility and introducing cutting-edge methods like vitrification (“snap freezing”) to improve embryo survival rates. Over its history, more than 50,000 babies have been born with their assistance. Clinical results are not reported as drug trial outcomes but measured by live birth rates from ART cycles.